More Taysha Gene Therapies, Inc. news Taysha Gene Therapies, Inc.NASDAQ: TSHA Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome Jan 6, 2026 · Issued by Taysha Gene Therapies, Inc. As issuedPlain English Watch Taysha Gene Therapies explain it↗Taysha Gene Therapies, Inc. (TSHA) Q2 2026 Earnings Call · Replay · Aug 11First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to
